卡立普多
参考资料

↑  . drugs.com.   [2017-04-16]. （原始内容存档于2017-08-31）.
1 2 3  Carrasco A. . Carrasco Ruiz MA, Chavez Pulido X, Morales E  (编). . Diccion I 65th. Mexico City: PLM Latinoamérica. 2019-09-13: 222  [2021-06-13]. ISBN 978-607-625-072-3. （原始内容存档于2023-02-08） （西班牙语）.
1 2 3 4 5 6 7  . Drugs.com. American Society of Health-System Pharmacists.   [2019-04-08]. （原始内容存档于2019-06-18） （英语）.
↑  . dailymed.nlm.nih.gov.   [2019-04-08]. （原始内容存档于2020-11-24）.
↑  . European Medicines Agency. 2007-11-15  [2019-04-08]. （原始内容存档于2019-04-08）.
↑  . ClinCalc.   [2022-10-07]. （原始内容存档于2020-07-08）.
1 2 3  . MedlinePlus. National Library of Medicine.   [2019-05-06]. （原始内容存档于2019-06-18）.
↑  Kamin I, Shaskan DA. . The American Journal of Psychiatry. June 1959, 115 (12): 1123–1124. PMID 13649976. doi:10.1176/ajp.115.12.1123-a.
↑  Hollister LE. . Journal of Psychoactive Drugs. 1983, 15 (1–2): 9–13. PMID 6350551. doi:10.1080/02791072.1983.10472117.
↑  Gaillard Y, Billault F, Pépin G. . Forensic Science International. May 1997, 86 (3): 173–180. PMID 9180026. doi:10.1016/S0379-0738(97)02128-2.
↑  Allen MD, Greenblatt DJ, Noel BJ. . Clinical Toxicology. December 1977, 11 (5): 501–515. PMID 608316. doi:10.3109/15563657708988216.
↑  Kintz P, Tracqui A, Mangin P, Lugnier AA. . The American Journal of Forensic Medicine and Pathology. June 1988, 9 (2): 139–140. PMID 3381792. doi:10.1097/00000433-198806000-00009.
↑  Eeckhout E, Huyghens L, Loef B, Maes V, Sennesael J. . Intensive Care Medicine. 1988, 14 (4): 437–438. PMID 3403779. S2CID 2784867. doi:10.1007/BF00262904.
↑  Lhoste F, Lemaire F, Rapin M. . The New England Journal of Medicine. April 1977, 296 (17): 1004. PMID 846530. doi:10.1056/NEJM197704282961717.
↑  Bedson HS. . Lancet. February 1959, 1 (7067): 288–290. PMID 13632000. doi:10.1016/S0140-6736(59)90209-0.
↑  Blumberg AG, Rosett HL, Dobrow A. . Annals of Internal Medicine. September 1959, 51 (3): 607–612. PMID 13801701. doi:10.7326/0003-4819-51-3-607.
↑  . TOXNET. National Library of Medicine.   [2019-05-06]. （原始内容存档于2019-05-06）.
↑  NCQA's HEDIS Measure: Use of High Risk Medications in the Elderly 的存檔，存档日期1 February 2010.
↑  . Pain o Soma medicines. 2021-03-19  [2021-04-29]. （原始内容存档于2023-02-09） （美国英语）.
↑  Barker MJ, Greenwood KM, Jackson M, Crowe SF. . Archives of Clinical Neuropsychology. April 2004, 19 (3): 437–454. PMID 15033227. doi:10.1016/S0887-6177(03)00096-9 .
↑  Horsfall JT, Sprague JE. . Basic & Clinical Pharmacology & Toxicology. February 2017, 120 (2): 115–119. PMID 27550152. S2CID 25909460. doi:10.1111/bcpt.12655 .
↑  .   [2011-04-29]. （原始内容存档于2011-04-17）.
↑  .   [2010-04-19]. （原始内容存档于2011-07-15）.
↑   (PDF). Drug Enforcement Administration, Diversion Control Division, Drug & Chemical Evaluation Section. U.S. Department of Justice. December 2019  [2023-02-08]. （原始内容存档 (PDF)于2023-01-03）.
↑  Madea B, Musshoff F. . Deutsches Ärzteblatt International. May 2009, 106 (20): 341–347. PMC 2689633 . PMID 19547737. doi:10.3238/arztebl.2009.0341.
↑  Duke A. . CNN Entertainment. 2014-07-22  [2019-02-24]. （原始内容存档于2019-05-07）.
↑  Conermann T, Christian D. . . Treasure Island (FL): StatPearls Publishing. 2022  [2022-02-23]. PMID 31971718. （原始内容存档于2021-05-18）.
↑  Dean L. Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kattman BL, Malheiro AJ, Dean L , 编. . Medical Genetics Summaries. 2017-04-04  [2023-02-08]. PMID 28520382. （原始内容存档于2022-08-18）.
↑  Miller JG, ed. The pharmacology and clinical usefulness of carisoprodol. Detroit:Wayne State University; 1959.
↑  Berger FM, Kletzkin M, Ludwig BJ, Margolin S. . Annals of the New York Academy of Sciences. March 1960, 86 (1): 90–107. Bibcode:1960NYASA..86...90B. PMID 13799302. S2CID 11909344. doi:10.1111/j.1749-6632.1960.tb42792.x.
↑  Bramness JG, Furu K, Engeland A, Skurtveit S. . British Journal of Clinical Pharmacology. August 2007, 64 (2): 210–218. PMC 2000626 . PMID 17298482. doi:10.1111/j.1365-2125.2007.02847.x.
↑   [Somadril is withdrawn from the market]. Norwegian Medicines Agency. 2008-04-20  [2010-03-12]. （原始内容存档于2011-07-16） （挪威语）.
↑   (PDF). EMEA.   [2008-05-12]. （原始内容 (PDF)存档于2009-07-18）.
↑   [Marketing of Somadril and Somadril is recommended to cease temporarily]. 2007-11-16  [2009-05-09]. （原始内容存档于2014-07-23） （瑞典语）.
↑  US Department of Justice.  (PDF). Federal Register. 2011, 76 (238): 77330–77360  [2012-02-01]. （原始内容存档 (PDF)于2012-03-16）.
↑  . the-rheumatologist.org.   [2017-08-31]. （原始内容存档于2015-05-07）.
↑  . National Association of Pharmacy Regulatory Authorities. 2009  [2014-01-07]. （原始内容 (ASP)存档于2014-02-01）.
↑  For British Columbia, see library.bcpharmacists.org/D-Legislation_Standards 的存檔，存档日期17 December 2013.
↑  . Jakarta Globe. 2017-09-14  [2023-02-08]. （原始内容存档于2017-09-14）.